Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease



Status:Completed
Conditions:Cancer, Pulmonary
Therapuetic Areas:Oncology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:March 2014
End Date:August 7, 2017

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease Using the ESAS-Sarcoma Modified Questionnaire

The purpose of this study is to evaluate the role of palliative surgery in improving Quality
of Life (QoL) and symptom control for patients who present with a Soft Tissue Sarcoma (STS)
and metastatic lung disease. Responses to clinical Edmonton Symptom Assessment System -
Sarcoma Modified ( ESAS-SM) questionnaire for patients who have undergone surgery for
resection of the primary tumour will be compared to those that are unable to have surgery.
Data collected from this questionnaire can highlight the benefits in patients' QoL who
receive palliative surgical resection, and whether these benefits surmount those who are not
treated with palliative surgery.


Inclusion Criteria:

- Patients with soft tissue sarcoma with at least one pulmonary metastasis

- Metastatic lung disease must have been present at time of initial presentation

Exclusion Criteria:

- All patients under 18 will be excluded

- Patients who have been previously undergone surgical resection of the primary tumor
We found this trial at
1
site
Duke University Health System
Durham, North Carolina
Principal Investigator: William Eward, MD
?
mi
from
Durham, NC
Click here to add this to my saved trials